Regarding the presence of KRAS mutation within tumor tissues in all 18 patients, only 12 patients in which sufficient specimens could be obtained by fine needle aspiration (FNA) biopsy and one patient with a peritoneal dissemination specimen revealed KRAS codon 12/13 mutations within tumor tissue samples. This evidence concerns the gene KRAS and neoplasm.